These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35778290)

  • 1. Proficiency testing for SARS-CoV-2 whole genome sequencing.
    Lau KA; Horan K; Gonçalves da Silva A; Kaufer A; Theis T; Ballard SA; Rawlinson WD
    Pathology; 2022 Aug; 54(5):615-622. PubMed ID: 35778290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program.
    Lau KA; Foster CSP; Theis T; Draper J; Sullivan MJ; Ballard S; Rawlinson WD
    Pathology; 2024 Aug; 56(5):717-725. PubMed ID: 38729860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories.
    Lau KA; Gonçalves da Silva A; Theis T; Gray J; Ballard SA; Rawlinson WD
    Pathology; 2021 Dec; 53(7):902-911. PubMed ID: 34274166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.
    Zufan SE; Lau KA; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson WD; Ballard SA; Stinear TP; Howden BP; Jennison AV; Seemann T
    Microb Genom; 2023 Nov; 9(11):. PubMed ID: 38019123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022.
    Sørensen LH; Pedersen SK; Jensen JD; Lacy-Roberts N; Andrea A; S M Brouwer M; Veldman KT; Lou Y; Hoffmann M; S Hendriksen R
    mSystems; 2024 Sep; 9(9):e0016024. PubMed ID: 39105591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.
    Xiaoli L; Hagey JV; Park DJ; Gulvik CA; Young EL; Alikhan NF; Lawsin A; Hassell N; Knipe K; Oakeson KF; Retchless AC; Shakya M; Lo CC; Chain P; Page AJ; Metcalf BJ; Su M; Rowell J; Vidyaprakash E; Paden CR; Huang AD; Roellig D; Patel K; Winglee K; Weigand MR; Katz LS
    PeerJ; 2022; 10():e13821. PubMed ID: 36093336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories.
    Lau KA; Kaufer A; Gray J; Theis T; Rawlinson WD
    Pathology; 2022 Jun; 54(4):472-478. PubMed ID: 35440366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An implementation science approach to evaluating pathogen whole genome sequencing in public health.
    Ferdinand AS; Kelaher M; Lane CR; da Silva AG; Sherry NL; Ballard SA; Andersson P; Hoang T; Denholm JT; Easton M; Howden BP; Williamson DA
    Genome Med; 2021 Jul; 13(1):121. PubMed ID: 34321076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
    Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
    Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet.
    Smith EA; Libuit KG; Kapsak CJ; Scribner MR; Wright SM; Bell J; Morales C; Crumpler M; Messenger S; Hacker JK; Ledin K; Glaser C; Jacobson K; Sevinsky JR; Wadford DA
    Microb Genom; 2023 Jun; 9(6):. PubMed ID: 37267020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of California COVIDNet - a multi-sector collaboration for statewide SARS-CoV-2 genomic surveillance.
    Wadford DA; Baumrind N; Baylis EF; Bell JM; Bouchard EL; Crumpler M; Foote EM; Gilliam S; Glaser CA; Hacker JK; Ledin K; Messenger SL; Morales C; Smith EA; Sevinsky JR; Corbett-Detig RB; DeRisi J; Jacobson K
    Front Public Health; 2023; 11():1249614. PubMed ID: 37937074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Inter-Laboratory Differences in SARS-CoV-2 Consensus Genome Assemblies between Public Health Laboratories in Australia.
    Foster CSP; Stelzer-Braid S; Deveson IW; Bull RA; Yeang M; Au JP; Ruiz Silva M; van Hal SJ; Rockett RJ; Sintchenko V; Kim KW; Rawlinson WD
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations.
    Spiess K; Gunalan V; Marving E; Nielsen SH; Jørgensen MGP; Fomsgaard AS; Nielsen L; Alfaro-Núñez A; Karst SM; ; Mortensen S; Rasmussen M; Lassaunière R; Rosenstierne MW; Polacek C; Fonager J; Cohen AS; Nielsen C; Fomsgaard A
    Microbiol Spectr; 2023 Feb; 11(1):e0359122. PubMed ID: 36625603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.
    Tacker DH; Bashleben C; Long TC; Theel ES; Knight V; Kadkhoda K; Rhoads DD; Linden MA; Fink SL
    Arch Pathol Lab Med; 2021 May; 145(5):536-542. PubMed ID: 33461214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus.
    Theis T; Lau KA; Gray JL; Oxenford CJ; Walker GJ; Rawlinson WD
    J Med Virol; 2018 Dec; 90(12):1827-1833. PubMed ID: 30016543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program.
    Jung A; Droit L; Febles B; Fronick C; Cook L; Handley SA; Parikh BA; Wang D
    Microbiol Spectr; 2024 Aug; 12(8):e0422523. PubMed ID: 38912809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India - An experience from a designated provider laboratory.
    Manchanda V; Siddiqui O; Meena K; Sharma A; Saxena S
    Indian J Med Microbiol; 2024; 49():100577. PubMed ID: 38588879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of whole-genome sequencing to inform epidemiologic investigations of SARS-CoV-2 clusters in acute-care hospitals.
    Rader TS; Srinivasa VR; Griffith MP; Waggle K; Pless L; Chung A; Wagester S; Harrison LH; Snyder GM
    Infect Control Hosp Epidemiol; 2024 Feb; 45(2):144-149. PubMed ID: 38130169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a national proficiency test for SARS-CoV-2 detection by PCR in Colombia.
    Dávila SL; Leguizamón JE; León AF; Holguín K; Barros EC; Gomez SY
    J Glob Health; 2023 Oct; 13():06029. PubMed ID: 37824175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.